BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 36062762)

  • 41. Radiomics in Gastric Cancer: First Clinical Investigation to Predict Lymph Vascular Invasion and Survival Outcome Using
    Yang L; Chu W; Li M; Xu P; Wang M; Peng M; Wang K; Zhang L
    Front Oncol; 2022; 12():836098. PubMed ID: 35433451
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Refining pathological evaluation of neoadjuvant therapy for adenocarcinoma of the esophagus.
    Noble F; Nolan L; Bateman AC; Byrne JP; Kelly JJ; Bailey IS; Sharland DM; Rees CN; Iveson TJ; Underwood TJ; Bateman AR
    World J Gastroenterol; 2013 Dec; 19(48):9282-93. PubMed ID: 24409055
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Development and external validation of a non-invasive imaging biomarker to estimate the microsatellite instability status of gastric cancer and its prognostic value: The combination of clinical and quantitative CT-imaging features.
    Zhao H; Gao J; Bai B; Wang R; Yu J; Lu H; Cheng M; Liang P
    Eur J Radiol; 2023 May; 162():110719. PubMed ID: 36764010
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Delta-radiomics and response to neoadjuvant treatment in locally advanced gastric cancer-a multicenter study of GIRCG (Italian Research Group for Gastric Cancer).
    Mazzei MA; Di Giacomo L; Bagnacci G; Nardone V; Gentili F; Lucii G; Tini P; Marrelli D; Morgagni P; Mura G; Baiocchi GL; Pittiani F; Volterrani L; Roviello F
    Quant Imaging Med Surg; 2021 Jun; 11(6):2376-2387. PubMed ID: 34079708
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Which is the optimal management for locally advanced gastric cancer patients with TRG 0 and 1 after R0 resection?
    Ma F; Zhang Y; Peng L; Zhang Z; Yang W; Chai J; Zhang B; Ji S; Hua Y; Chen X; Luo S
    Ann Transl Med; 2020 Aug; 8(15):948. PubMed ID: 32953748
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A radiomics-based model for prediction of lymph node metastasis in gastric cancer.
    Gao X; Ma T; Cui J; Zhang Y; Wang L; Li H; Ye Z
    Eur J Radiol; 2020 Aug; 129():109069. PubMed ID: 32464581
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The role of computed tomography features in assessing response to neoadjuvant chemotherapy in locally advanced gastric cancer.
    Wei C; He Y; Luo M; Chen G; Nie R; Chen X; Zhou Z; Chen Y
    BMC Cancer; 2023 Nov; 23(1):1157. PubMed ID: 38012547
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A machine learning model that classifies breast cancer pathologic complete response on MRI post-neoadjuvant chemotherapy.
    Sutton EJ; Onishi N; Fehr DA; Dashevsky BZ; Sadinski M; Pinker K; Martinez DF; Brogi E; Braunstein L; Razavi P; El-Tamer M; Sacchini V; Deasy JO; Morris EA; Veeraraghavan H
    Breast Cancer Res; 2020 May; 22(1):57. PubMed ID: 32466777
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Prognostic value and clinicopathological correlation of the tumor regression grade in neoadjuvant chemotherapy for gastric adenocarcinoma: a retrospective cohort study.
    Wang Y; Xu H; Hu C; Yu P; Bao Z; Zhang Y; Zhang R; Zhang S; Li B; Aerts JM; Xu Z; Cheng X
    J Gastrointest Oncol; 2022 Jun; 13(3):1046-1057. PubMed ID: 35837180
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Comparison of five tumor regression grading systems for gastric adenocarcinoma after neoadjuvant chemotherapy: a retrospective study of 192 cases from National Cancer Center in China.
    Zhu Y; Sun Y; Hu S; Jiang Y; Yue J; Xue X; Yang L; Xue L
    BMC Gastroenterol; 2017 Mar; 17(1):41. PubMed ID: 28292272
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Computed tomography-based radiomics for prediction of neoadjuvant chemotherapy outcomes in locally advanced gastric cancer: A pilot study.
    Li Z; Zhang D; Dai Y; Dong J; Wu L; Li Y; Cheng Z; Ding Y; Liu Z
    Chin J Cancer Res; 2018 Aug; 30(4):406-414. PubMed ID: 30210220
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Non-invasive CT imaging biomarker to predict immunotherapy response in gastric cancer: a multicenter study.
    Huang W; Xiong W; Tang L; Chen C; Yuan Q; Zhang C; Zhou K; Sun Z; Zhang T; Han Z; Feng H; Liang X; Zhong Y; Deng H; Yu L; Xu Y; Wang W; Shen L; Li G; Jiang Y
    J Immunother Cancer; 2023 Nov; 11(11):. PubMed ID: 38179695
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Non-invasive measurement of tumor immune microenvironment and prediction of survival and chemotherapeutic benefits from
    Li J; Zhang C; Guo H; Li S; You Y; Zheng P; Zhang H; Wang H; Bai J
    Front Immunol; 2022; 13():1019386. PubMed ID: 36311742
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Predicting Chemotherapeutic Response for Far-advanced Gastric Cancer by Radiomics with Deep Learning Semi-automatic Segmentation.
    Tan JW; Wang L; Chen Y; Xi W; Ji J; Wang L; Xu X; Zou LK; Feng JX; Zhang J; Zhang H
    J Cancer; 2020; 11(24):7224-7236. PubMed ID: 33193886
    [No Abstract]   [Full Text] [Related]  

  • 55. Digital histopathological images of biopsy predict response to neoadjuvant chemotherapy for locally advanced gastric cancer.
    Zhou Z; Ren Y; Zhang Z; Guan T; Wang Z; Chen W; Luo T; Li G
    Gastric Cancer; 2023 Sep; 26(5):734-742. PubMed ID: 37322381
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Preoperative computed tomography-guided disease-free survival prediction in gastric cancer: a multicenter radiomics study.
    Wang S; Feng C; Dong D; Li H; Zhou J; Ye Y; Liu Z; Tian J; Wang Y
    Med Phys; 2020 Oct; 47(10):4862-4871. PubMed ID: 32592224
    [TBL] [Abstract][Full Text] [Related]  

  • 57. PET/CT radiomics in breast cancer: promising tool for prediction of pathological response to neoadjuvant chemotherapy.
    Antunovic L; De Sanctis R; Cozzi L; Kirienko M; Sagona A; Torrisi R; Tinterri C; Santoro A; Chiti A; Zelic R; Sollini M
    Eur J Nucl Med Mol Imaging; 2019 Jul; 46(7):1468-1477. PubMed ID: 30915523
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Intratumoral and peritumoral radiomics for preoperative prediction of neoadjuvant chemotherapy effect in breast cancer based on contrast-enhanced spectral mammography.
    Mao N; Shi Y; Lian C; Wang Z; Zhang K; Xie H; Zhang H; Chen Q; Cheng G; Xu C; Dai Y
    Eur Radiol; 2022 May; 32(5):3207-3219. PubMed ID: 35066632
    [TBL] [Abstract][Full Text] [Related]  

  • 59. T
    Crombé A; Périer C; Kind M; De Senneville BD; Le Loarer F; Italiano A; Buy X; Saut O
    J Magn Reson Imaging; 2019 Aug; 50(2):497-510. PubMed ID: 30569552
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Simulation CT-based radiomics for prediction of response after neoadjuvant chemo-radiotherapy in patients with locally advanced rectal cancer.
    Bonomo P; Socarras Fernandez J; Thorwarth D; Casati M; Livi L; Zips D; Gani C
    Radiat Oncol; 2022 Apr; 17(1):84. PubMed ID: 35484597
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.